Sumithira Vasu, MD
College of Medicine
>Graft vs Host Disease ● Leukemia, Myeloid, Acute ● Leukemia ● Hemoglobinuria, Paroxysmal ● Hematologic Cancer ● Lymphoma ● Multiple Myeloma
Sumithira Vasu, MBBS, is a member of the Leukemia Research Program at the OSUCCC – James, where her research focuses on acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation.In particular, she is interested in pharmacologic and immunologic therapies in this transplantation to pre-emptively manage relapse and graft-versus-host disease. One of her recent studies suggests that Janus kinase 1/2 inhibitor therapy should be continued close to the start of conditioning therapy in patients who undergo allogeneic hematopoietic cell transplantation for myelofibrosis. Dr. Vasu also serves as scientific director of the Blood and Marrow Transplantation Program and as medical director of the Cell Therapy Lab, Blood and Marrow Transplantation Section. She has co-authored numerous articles in well-respected publications, including Biology of Blood and Marrow Transplantation, Leukemia & Lymphoma, Blood and Bone Marrow Transplantation.
Starling Loving Hall
320 W 10th Ave, Columbus, OH 43210